CAR T-cell therapy: Navigating the Canadian landscape
Join us, in partnership with Cell Therapy Transplant Canada (CTTC), for an insightful 90-minute webcast exploring the evolving landscape of CAR T-cell therapy in Canada. Whatever your blood cancer experience, or if you are a healthcare professional, this webcast will equip you with valuable knowledge to better understand and navigate the CAR-T experience in Canada.
We’ll dive into an environmental scan of current trends and innovations, discuss regional access to treatment, and share practical tips for individuals receiving CAR-T, and their caregivers, planning to travel for care. Presenters in this webcast will include:
- Dr. Kevin Hay, University of Calgary, on the medical landscape today in Canada for CAR-T, and access for patients to this therapy
- Dr. Cindy Hickey, Memorial University of Newfoundland, on the rural component of accessing CAR-T therapy in Canada, and tips for travel to treatment.
- Blood cancer survivor sharing lived experience undergoing CAR-T therapy.
Dr. Hay is a hematologist at the Arthur J.E. Child Comprehensive Cancer Centre and Associate Professor in Medicine at the University of Calgary with a focus on development and translation of adoptive cell therapies. He completed his MSc and MD at the University of Manitoba, before undergoing Internal Medicine and Hematology training at UBC. He then took a postdoctoral fellowship position at Fred Hutchinson Cancer Research Center (Seattle, USA) before returning to Canada as an Assistant Professor at UBC in the BC Cancer Leukemia, Blood, and Marrow Transplant Program.
While in BC Dr, Hay developed a CAR-T research program and continues to serve as Medical Director of the BC Cancer Conconi Family Immunotherapy Laboratory in Victoria, which is dedicated to the manufacturing of cellular immunotherapies. He moved to Calgary in Fall 2023 to join the Riddell Centre for Cancer Immunotherapy and continues to lead biomanufacturing efforts, clinical research, and a research laboratory focused on improving cellular immunotherapies.
Dr. Cindy Hickey is a hematologist at NL Health Services and Clinical Assistant Professor in the Division of Hematology at Memorial University of Newfoundland. After receiving her Doctor of Medicine from MUN, she completed her Core Internal Medicine residency and Hematology subspecialty residency at Dalhousie University. She subsequently completed an Advanced Fellowship in Allogeneic Stem Cell Transplant at the Dana-Farber Cancer Institute in Boston, MA.
Her clinical research focuses on haploidentical transplant, graft failure and MDS/acute leukemia. Her work has been presented at international meetings including the American Society of Hematology (ASH) and Center for International Blood and Marrow Transplant Research (CIBMTR) and she is the recipient of the ASH abstract achievement award. She now serves as the allogeneic stem cell transplant lead of the Newfoundland and Labrador Cellular Therapy and Transplant Program, focusing on improving outcomes of transplant patients in both the urban and rural setting.
This event is organized in partnership with:
